Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression
Top Cited Papers
Open Access
- 27 May 2008
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 47 (9) , 755-765
- https://doi.org/10.1002/gcc.20577
Abstract
Recurrent karyotypic abnormalities are a characteristic feature of cervical cancer (CC) cells, which may result in deregulated expression of important genes that contribute to tumor initiation and progression. To examine the role of gain of the long arm of chromosome 20 (20q), one of the common chromosomal gains in CC, we evaluated CC at various stages of progression using single nucleotide polymorphism (SNP) array, gene expression profiling, and fluorescence in situ hybridization (FISH) analyses. This analysis revealed copy number increase (CNI) of 20q in >50% of invasive CC and identified two focal amplicons at 20q11.2 and 20q13.13 in a subset of tumors. We further demonstrate that the acquisition of 20q gain occurs at an early stage in CC development and the high‐grade squamous intraepithelial lesions (HSIL) that exhibit 20q CNI are associated (P = 0.05) with persistence or progression to invasive cancer. We identified a total of 26 overexpressed genes as consequence of 20q gain (N = 14), as targets of amplicon 1 (N = 9; two genes also commonly expressed with 20q gain) and amplicon 2 (N = 6; one gene also commonly expressed with 20q gain). These include a number of functionally important genes in cell cycle regulation (E2F1, TPX2, KIF3B, PIGT, and B4GALT5), nuclear function (CSEL1), viral replication (PSMA7 and LAMA5), methylation and chromatin remodeling (ASXL1, AHCY, and C20orf20), and transcription regulation (TCEA2). Our findings implicate a role for these genes in CC tumorigenesis, represent an important step toward the development of clinically significant biomarkers, and form a framework for testing as molecular therapeutic targets.Keywords
This publication has 27 references indexed in Scilit:
- Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for CovariatesCancer Research, 2007
- Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancerBMC Genomics, 2007
- Keratinocyte-Secreted Laminin 5 Can Function as a Transient Receptor for Human Papillomaviruses by Binding Virions and Transferring Them to Adjacent CellsJournal of Virology, 2006
- High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridizationOncogene, 2004
- Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteinsInternational Journal of Cancer, 2003
- Genome amplification of chromosome 20 in breast cancer.Breast Cancer Research and Treatment, 2003
- Comprehensive molecular cytogenetic characterization of cervical cancer cell linesGenes, Chromosomes and Cancer, 2003
- Genetic events during the transformation of a tamoxifen-sensitive human breast cancer cell line into a drug-resistant cloneCancer Genetics and Cytogenetics, 2001
- Dominant genetic alterations in immortalization: Role for 20q gainGenes, Chromosomes and Cancer, 1999
- Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.Proceedings of the National Academy of Sciences, 1996